Skip to main content
Hit enter to search or ESC to close
Search
Close Search
Menu
About
Leadership
Board of Directors
Portfolio
Hepatocellular Carcinoma
Gravitas Life Sciences
Newsroom
Investors
Investor Overview
Press Releases
Presentations
Stock Information
SEC Filings
Corporate Governance
Contact
Media Placements
Treating NASH and Other Fatty Liver Diseases Using Drugs Developed Around Cyclophilin Inhibition with Dr. Robert Foster Hepion Pharmaceuticals [Empowered Patient Podcast]
By
Admin
April 18, 2022
No Comments
https://hepionpharma.com/wp-content/uploads/2022/04/EP220322_Hepion.mp3
Share
Share
Share
Pin
Close Menu
About
Leadership
Board of Directors
Portfolio
Hepatocellular Carcinoma
Gravitas Life Sciences
Newsroom
Investors
Investor Overview
Press Releases
Presentations
Stock Information
SEC Filings
Corporate Governance
Contact